People living with one of the most common types of alopecia could soon have access to treatment on the NHS in Scotland for the first time.

The drug – called Ritlecitinib – will go before the Scottish Medicines Consortium this week after it was approved for NHS use in England last month.

Although the daily pill won’t cure the condition, it could provide treatment to some who have severe alopecia areata, like 21-year-old Megan McCready, from Clydebank.

Since her diagnosis at the age of 12, Megan has learned to embrace her condition and now supports other young people going through the same thing.

Video by Morgan Spence and Hazel Martin



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is 7 times 4?

Explore More

from first cases to vaccinations

Credit: Unsplash/CC0 Public Domain As the Democratic Republic of Congo launches a vaccination campaign amid a flare-up of the sometimes deadly illness mpox, AFP looks at how the virus developed.

Just a moment…

Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until

Hep C: We’re closer than ever to solving mystery of deadly virus

Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year. So far, no treatment has successfully managed